Abstract
The ability of synthetic peptide analogues of foot-and-mouth disease virus VP1 capsid protein to induce T-cell proliferation in vitro following immunization of sheep with the uncoupled peptides was assessed. Elevated T-cell responses were obtained to a 21-residue peptide containing VP1 residues 141-158, and a 40-residue peptide containing residues 200-213 and 141-158 linked via a diproline-serine spacer. In contrast, no significant T-cell response was obtained with a 19-residue peptide containing residues 200-213 alone. In an attempt to engineer T-cell reactivity to this peptide, a sequence motif found in many peptides recognized by human or mouse T-cells was introduced by amino acid substitution. Substitution of a glycine or an aspartic acid for an alanine at position 207 in the 19-residue peptide resulted in the introduction of two such motifs running consecutively. Immunization of sheep with these peptides resulted in significant T-cell proliferative responses and elevated antibody responses. Analysis of further sequence variants showed that T-cell responsiveness was maintained with peptides containing single amino acid changes within these motifs, provided position 207 was glycine. The results thus suggest that increased T-cell reactivity, might be engineered via sequence manipulation of the 200-213 component of the 40-residue synthetic peptide. Such an additional T-cell epitope in the 40-residue peptide could potentially result in superior neutralizing antibody responses directed against the major epitope in residues 141-160 of VP1.
Original language | English |
---|---|
Pages (from-to) | 255-66 |
Number of pages | 12 |
Journal | Veterinary Immunology and Immunopathology |
Volume | 31 |
Issue number | 3-4 |
Publication status | Published - Mar 1992 |
Keywords
- Amino Acid Sequence
- Amino Acids
- Animals
- Antibodies, Viral
- Antibody Formation
- Aphthovirus
- Capsid
- Epitopes
- Foot-and-Mouth Disease
- Lymphocyte Activation
- Molecular Sequence Data
- Peptides
- Sheep
- Sheep Diseases
- T-Lymphocytes
- Viral Proteins